PNTUnknown
POINT Biopharma Global Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for POINT Biopharma Global Inc. (PNT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are PNT insiders buying or selling?
POINT Biopharma Global Inc. insiders reported 7 open-market buys ($449.0K) and 2 sells ($217.9M) across 9 Form 4 filings — a net selling position of $217.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Dec 20, 2023)
Total Form 4 filings
9
SEC EDGAR
Insider filers
9
Insider buys (7)
$449.0K
Insider sells (2)
$217.9M
Insider sentiment
Net sellingNet insider flow of $217.4M in net selling.
Recent PNT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 20, 2023 | Mark N Lampert | Other | Sale | 17.2M | $12.45 | $213.7M |
| Dec 1, 2022 | Joe A. Mccann | Chief Executive Officer | Purchase | 2.2K | $6.64 | $14.3K |
| Nov 28, 2022 | David Charles Lubner | Director | Purchase | 3.6K | $6.85 | $24.7K |
| Nov 28, 2022 | Gerald L. Hogue | Director | Purchase | 3.7K | $6.82 | $24.9K |
| Nov 28, 2022 | Rajesh Malik | Director | Purchase | 3.7K | $6.66 | $24.6K |
| Nov 23, 2022 | Yael Margolin | Director | Purchase | 1.7K | $6.56 | $11.2K |
| Nov 21, 2022 | Jonathan R. Goodman | Director | Purchase | 6.0K | $6.33 | $38.0K |
| Nov 21, 2022 | SILBER ALLAN C | Executive Chairman | Purchase | 50.0K | $6.22 | $311.2K |
| May 26, 2022 | Neil E. Fleshner | Chief Medical Officer | Sale | 564.2K | $7.51 | $4.2M |
Showing the 9 most recent of 9 Form 4 filings for POINT Biopharma Global Inc..
Most active PNT insiders
- David Charles Lubner1 filing
- Gerald L. Hogue1 filing
- Joe A. Mccann1 filing
- Jonathan R. Goodman1 filing
- Neil E. Fleshner1 filing
Ask anything about PNT insider activity
Use Trabud's AI agent to query POINT Biopharma Global Inc.'s Form 4 history in plain English — "Show me PNT CEO purchases this year" or compare it against any other ticker.
Open the AI agentPNT insider trading FAQ
Are POINT Biopharma Global Inc. insiders buying or selling?
Across 9 SEC Form 4 filings, POINT Biopharma Global Inc. (PNT) insiders reported 7 open-market purchases totaling $449.0K and 2 sales totaling $217.9M. That is a net selling position of $217.4M.
How many insiders trade PNT stock?
9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for POINT Biopharma Global Inc.. The most recent filing was accepted on Dec 20, 2023.
Where does Trabud get PNT insider trading data?
All PNT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.